Handelsvergunninghouder · Verenigde Staten
Cubist Pharms LLC
10 geneesmiddelen in 2 landen, als handelsvergunninghouder.
Geneesmiddelen
Alle geneesmiddelen die in de registers op zijn naam staan, actuele eerst.
10 geneesmiddelen
| Geneesmiddel | Werkzame stof | Land | Status | Toelating |
|---|---|---|---|---|
| CUBICIN250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Powder | Daptomycin | Verenigde Staten | Niet in de handel | 2003 |
| CUBICIN RF500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Powder | Daptomycin | Verenigde Staten | Niet in de handel | 2003 |
| DIFICID200mg · Tablet | Fidaxomicin | Verenigde Staten | In de handel | 2011 |
| DIFICID40mg/ml · For suspension | Fidaxomicin | Verenigde Staten | In de handel | 2020 |
| ENTEREG12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Alvimopan | Verenigde Staten | Niet in de handel | 2008 |
| SIVEXTRO200mg · Tablet | Tedizolid | Verenigde Staten | In de handel | 2014 |
| SIVEXTRO200mg/vial · Powder | Tedizolid | Verenigde Staten | In de handel | 2014 |
| ZERBAXA1gm base/vial; 0.5gm base/vial · Powder | Ceftolozane, Tazobactam | Verenigde Staten | In de handel | 2014 |
| CUBICIN500 mg / vial · Powder For Solution | Daptomycin | Canada | Vervallen | 2007 |
| CUBICIN RF500 mg / vial · Powder For Solution | Daptomycin | Canada | Vervallen | 2018 |